Welcome to the e-CCO Library Archive!

search
                             
search by: 
Filter:
P298. Are serum biomarkers predictive of capsule enteroscopy positive findings in patients with suspected Crohn's disease?
Authors:

P. Boal-Carvalho1, M. Barbosa1, B. Rosa1, M.-J. Moreira1, J. Cotter1, 1Centro Hospitalar Alto Ave, Gastrenterology, Guimarães, Portugal

P298. Dysregulation of the innate immune signalling in ulcerative colitis
P298. Effect of immunosuppressive and biologic therapy in patients with inflammatory bowel diseases and HBV or HCV infection – A multicentre retrospective study
P298

Validation of the mobile Health Index (mHI) for remote monitoring of IBD disease activity

Authors:

W.K. van Deen*1, A.E. van der Meulen- de Jong2, N.K. Parekh3, Y. Muyshondt3, E. Kane1, L. Eimers1, E.K. Inserra1, A. Zand1, C.A. DiNicola1, S. Bhatia3, J.M. Choi1, C.Y. Ha1, M.G. van Oijen1, E. Esrailian1, D.W. Hommes1

1UCLA Center for Inflammatory Bowel Diseases, Division of Digestive Diseases, University of California, Los Angeles, Los Angeles, United States, 2Leiden University Medical Center, Gastroenterology and Hepatology, Leiden, Netherlands, 3UC Irvine, Digestive Disease Center, Irvine, United States

P299.

Vagus nerve stimulation in Crohn's disease

Authors:

B. Bonaz1,2, S. Pellissier2, N. Mathieu1, D. Hoffmann3, C. Trocmé4, M. Baudrant-Boga1, V. Sinniger2, C. Picq2,5, O. David2, L. Vercueil3, C. Dantzer6, J.-L. Cracowski7, D. Clarençon5, 1CHU de Grenoble, Clinique Universitaire d'Hépato-Gastroentérologie, Grenoble, France, 2Grenoble Institute of Neurosciences (GIN, INSERM U836), CHU Grenoble, Grenoble Cedex 09, France, 3Pôle de Neurologie, Département de Neurochirurgie, Grenoble Cedex 09, France, 4Institut de Biologie, CHU Grenoble, Grenoble Cedex 09, France, 5IRBA, Biologie, La Tronche, France, 6Laboratoire Inter-Universitaire de Psychologie (EA4145 UPMF/UDS), Université de Savoie, Chambéry, France, 7Centre d'Investigation Clinique, CHU Grenoble, Grenoble Cedex 09, France

P299. Are regular repeated endoscopies necessary in patients with inflammatory bowel diseases?
Authors:

D.H. Kim1, S.M. Yim1, A.R. Choi1, H.J. Lee1, H.W. Jang1, S.H. Jung1, S.J. Park1, S.P. Hong1, T.I. Kim1, W.H. Kim1, J.H. Cheon1, 1Yonsei University College of Medicine, Internal Medicine, Seoul, South Korea

P299. Comparative evaluation of outcomes in adolescents with IBD on transfer from paediatric to adult health care services: A case for structured transition
P299. Mucinous adenocarcinoma in perianal Crohn's disease after biological therapy: A four cases report
P299

Ulcerative colitis and paediatric liver transplantation for primary sclerosis cholangitis - multi-case report

Authors:

P. Czubkowski*, J. Pawlowska, M. Wozniak, K. Zieniewska-Pingwara, I. Jankowska, J. Kierkus

The Children's Memorial Health Institute, Department of Gastroenterology, Hepatology, Feeding Disorders and Pediatrics, Warsaw, Poland

P300.

Vaccination routines during anti-TNF treatment in IBD: Do patients adhere to ECCO's guidelines?

Authors:

K. Risager Christensen, C. Steenholdt, S. Schnoor Buhl, M.A. Ainsworth, O.Ø. Thomsen, J. Brynskov, Herlev University Hospital, Department of Gastroenterology, Herlev, Denmark

P300. Are outcomes following laparoscopic resection for inflammatory bowel disease in adults and children comparable?
Authors:

C.M. McMullin1, J. Morton1, S. Vickramarajah1, M. Brennan2, C. Salvestrini2, F. Torrente2, R. Heuschkel2, R.J. Davies1, 1Addenbrookes hospital, Cambridge University hospitals NHS Foundation trust, Cambridge Colorectal unit, Cambridge, United Kingdom, 2Addenbrookes hospital, Cambridge University hospitals NHS Foundation trust, Department of Paediatric Gastroenterology, Cambridge, United Kingdom

P300. Health related quality of life results through week 22 from the CERTIFI study, a multicenter, randomized, double-blind, placebo-controlled Phase2b study of ustekinumab in patients with moderately to severely active Crohn's disease
P300. Quality of life in Crohn's disease patients with endoscopic recurrence after surgery: Influence of thiopurine treatment
P300

Effect of vedolizumab on health-related quality of life (HRQoL) in patients with Crohn's disease

Authors:

W. Sandborn*1, W. Reinisch2, E.V. Loftus Jr3, R. Panaccione4, H. Doll5, H. Patel6, J. Xu7, K. Lasch8, A. Green9, B. Abhyankar10, R. Mody11

1University of California San Diego and UC San Diego Health System, Gastroenterology, San Diego, California, United States, 2McMaster University, Gastroenterology, Hamilton, ON, Canada, 3Mayo Clinic, Gastroenterology and Hepatology, Rochester, Minnesota, United States, 4University of Calgary, Medicine, Alberta, Canada, 5ICON plc, Patient Reported Outcomes, Oxford, United Kingdom, 6Immensity Consulting, Inc., Health Economics and Outcomes Research, Chicago, IL, United States, 7Takeda Pharmaceuticals International Co., Biostatistics, Cambridge, Massachusetts, United States, 8Takeda Pharmaceuticals International Inc., Medical Affairs, Deerfield, IL, United States, 9Takeda Global Research & Development Centre (Europe) Ltd., Statistics, London, United Kingdom, 10Takeda Global Research and Development Centre (Europe) Ltd., Clinical Science, London, United Kingdom, 11Takeda Pharmaceuticals International Inc., Global Outcomes and Epidemiology Research, Deerfield, IL, United States

P301.

Utility of faecal lactoferrin measurement in ulcerative colitis patients with granulocyte and monocyte adsorptive apheresis

Authors:

K. Hashiguchi, F. Takeshima, Y. Akazawa, K. Matsushima, H. Minami, H. Ishii, N. Yamaguchi, K. Shiozawa, K. Ohnita, H. Isomoto, K. Nakao, Nagasaki University, Department of Gastroenterology and Hepatology, Graduate School of Biomedical Sciences, Nagasaki, Japan

P301. A questionnaire study assessing clinicians' knowledge about the ionizing radiation used in investigations of patients with IBD
Authors:

B. Abdullah1, J. Lindsay2, 1Queen Mary, University of London, Barts and The London, School of Medicine, Uxbridge, London, United Kingdom, 2Barts and The london, United Kingdom

P301. Infliximab trough levels and anti-infliximab antibodies in rheumatoid arthritis and in IBD patients – A comparison from a single center
P301. Short-term effectiveness and impact on quality of life of iron carboxymaltose in the treatment of iron deficiency anemia associated with inflammatory bowel disease
P301

Vedolizumab for induction of remission in Crohn's disease in adults, a systematic review and meta-analysis

Authors:

M.C.W. Lam, N. Fu, B. Bressler, G. Rosenfeld*

University of British Columbia, Gastroenterology, Vancouver, Canada

P302.

Utility of “trough levels” determination and anti-infliximab antibodies in patients with inflammatory bowel disease. Estimation of individual pharmacokinetic parameters (PK) through population pharmacokinetic model

Authors:

G. Juan1,2, A. Alvariño3,4, L. Oltra4, N. Maroto4, N. Cano2, I. Ferrer2, J. Hinojosa2,4, 1Hospital de Manises, Farmacia Hospitalaria, Valencia, Spain, 2Hospital de Manises, Digestivo, Manises, Spain, 3Hospital de Manises, LABCO, Valencia, Spain, 4Hospital de Manises, Gastroenterology, Valencia, Spain